FDA Investigator: Patricia H. Dlugosz
- Patricia H. Dlugosz first started conducting FDA inspections in 2000, with the last inspection in 2011. Over that time, Patricia H. Dlugosz has conducted 92 inspections at 76 companies across 76 sites.
Get Patricia Dlugosz's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Eli Lilly And, Indianapolis | February 2001
Available Now - $199
Patricia H. Dlugosz
Human Drug Form 483
FDA 483 Catalent Pharma Solutions, Brussels | 2010
Out-of-stock
Patricia H. Dlugosz
Human Drug Form 483
FDA 483 Lilly France S.A.S., Fegersheim | 2010
Out-of-stock
Patricia H. Dlugosz
Human Drug Form 483
FDA 483 Alkermes Pharma Ireland Ltd. (Elan), Athlone | 2007
Out-of-stock
Patricia H. Dlugosz
Human Drug Form 483
FDA 483 Synthon Bv, Nijmegen | 2006
Out-of-stock
Patricia H. Dlugosz
Human Drug Form 483
FDA 483 Finetech Laboratories Ltd., Nesher | 2004
Out-of-stock
Patricia H. Dlugosz
Human Drug Form 483
FDA 483 Koffolk (1949), Ltd., Beer Sheba | 2004
Out-of-stock
Patricia H. Dlugosz
Animal Drugs & Feed Form 483
FDA 483 Analytical Control Systems, Inc, Fishers | 2003
Out-of-stock
Patricia H. Dlugosz
Animal Drugs & Feed Form 483
FDA 483 Priscilla Laboratories, Inc., Indianapolis | 2003
Out-of-stock
Patricia H. Dlugosz
Human Drug Form 483
FDA 483 National Gene Vector Laboratories, Indiana U. School of Med., Indianapolis | 2003
Out-of-stock
Patricia H. Dlugosz
Biologic Form 483
FDA 483 Hermiller, James M.D., Indianapolis | 2003
Out-of-stock
Patricia H. Dlugosz
Medical Devices & Rad Health Form 483
FDA 483 Covance Bioanalytical Services, LLC, Indianapolis | 2003
Out-of-stock
Patricia H. Dlugosz
Biologic Form 483
FDA 483 Giusseppe Pastore, M.D., Bari | 2002
Out-of-stock
Patricia H. Dlugosz
Human Drug Form 483
Co-Investigators (16)
- Marlon K. Turner, FDA Investigator
- Joseph R. Strelnik, FDA Investigator
- Steven C. Madzo, FDA Investigator
- Jennifer D. Hollstrom, FDA Investigator
- Kent C. Faul, FDA Investigator
- Barbara L. Rogolsky, FDA Investigator
- Darren S. Morgan, FDA Investigator
- Charles M. Spyr, FDA Investigator
- Susan P. Bruederle, FDA Investigator
- Charles I. Ahn, FDA Investigator
- Jean Blackstone Hill, FDA Investigator
- Thomas J. Arista, FDA Investigator
- Robert D. Tollefsen, FDA Investigator
- James L. Finn, FDA Investigator
- Jeffrey A. Sommers, FDA Investigator
- David L. Duncan, FDA Investigator